Learn more

MONTERO GIDA SANAYI VE TICARET ANONIM SIRKETI

Overview
  • Total Patents
    36
  • GoodIP Patent Rank
    43,380
  • Filing trend
    ⇧ 120.0%
About

MONTERO GIDA SANAYI VE TICARET ANONIM SIRKETI has a total of 36 patent applications. It increased the IP activity by 120.0%. Its first patent ever was published in 2017. It filed its patents most often in WIPO (World Intellectual Property Organization), Turkey and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and medical technology are BIOFILM LTD, ZHUHAI HENGQIN GENDE BIOTECH CO LTD and ALASTIN SKINCARE INC.

Patent filings in countries

World map showing MONTERO GIDA SANAYI VE TICARET ANONIM SIRKETIs patent filings in countries

Patent filings per year

Chart showing MONTERO GIDA SANAYI VE TICARET ANONIM SIRKETIs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Türkyilmaz Ali 10
#2 Ali̇ Türkyilmaz 8
#3 Toksöz Ahmet 7
#4 Zafer Toksöz 7
#5 Toksöz Zafer 7
#6 Ahmet Toksöz 7
#7 Güner Dicle 6
#8 Palantöken Arzu 5
#9 Toksoz Ahmet 4
#10 Gülay Yelken 4

Latest patents

Publication Filing date Title
WO2020022988A2 Plant-based topical compositions for baby skin care
EP3787654A2 Topical compositions for stretch marks on the skin
WO2020022989A2 Topical compositions for baby skin care
WO2019209228A2 Solid oral compositions comprising dried honey and herbal extracts
WO2019209223A2 Sensitive care and cleansing compositions
WO2019194779A2 Baby shampoo
WO2019194776A2 Topical composition for stimulating hair growth
WO2019209222A2 Topical compositions comprising tree nut oils
WO2019194775A2 A composition for the treatment of diseases of nipple and areola
WO2019203753A2 The pharmaceutical combination comprising dapoxetine, phosphodiesterase type-5 inhibitor and anti-emetic agent
WO2019070220A2 Hemostatic compositions
TR201722959A2 Solid oral formulations comprising herbal extracts
TR201715231A2 The pharmaceutical combination comprising dapoxetine and phosphodiesterase type-5
TR201713929A2 Hemostatic compositions of chitosan and alginate